Mandate

Vinge advises Alder II in conjunction with the acquisition of Scanacon

September 26, 2018 M&A

Alder II has entered into an agreement together with the management of the company to acquire the entire issued share capital of Scanacon Intressenter from the seller Verdane Capital.

Scanacon will be the first investment in Alder’s new fund, i.e. Alder II. Alder II is a Swedish based investment fund which invests in Nordic sustainable technology companies. The investments focus on established companies in the Nordic region.

Vinge’s team consisted of, among others, Johan Larsson, Albert Wållgren, Filip Brosset, Manne Bergström, Stina Bengtsson, Ludvig Wettergren and Andreas Lexhag which represented the purchaser Alder II in connection with the acquisition.  

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025